Summary
Circadian (≈24 hours) and other endogenous biological rhythms, detectable at all levels of organisation, constitute a temporal structure in all animal species, including man. Circadian, circannual, and other rhythmic changes in biological susceptibility and response of organisms to a large variety of physical and chemical agents, including medications and foods, are rather common phenomena. A better understanding of periodic and thus predictable changes in drug effects can be attained through consideration of three complementary concepts, the chronopharmacokinetics of a drug (rhythmic changes in its pharmacokinetics), the chronesthesy (rhythmic changes in susceptibility of target biosystems to the drug), and the chronergy (the drug-integrated overall effects).
The chronopharmacokinetics of many drugs have been evaluated in man including sodium salicylate, aspirin, indomethacin, paracetamol (acetaminophen), phenacetin, amidopyrine, theophylline, digitalis, Propranolol, clorazepate, hexobarbitone (hexobarbital), lithium, phenytoin (diphenylhydantoin), nortriptyline, ethanol, erythromycin, ampicillin, sulfasymazine, sulphanilamide, cisplatin (cis-diammine dichloroplatinum), d-xylose, ferrous sulphate, potassium chloride, hydrocortisone and prednisolone, among others. The roles presumably played by circadian rhythms in drug metabolising liver enzymes and kidney function are summarised, and the practical implications of chronopharmacokinetics, aiming both to improve in a quantitative manner the metabolic fate of a drug and its effectiveness, are discussed.
Similar content being viewed by others
References
Altmayer, P.; Mayer, D.; Mayersbach, H. von; Lücker, P.; Rindt, W. and Wetzelsberger, F.: Circadian variations in pharmacokinetic parameters after oral application of hexobarbital. Chronobiologia 6: 73 (1979).
Angeli, A.; Frairia, R.; de Paoli, R.; Fonzo, D. and Ceresa, F.: Diurnal variation of prednisolone binding to serum corticosteroid binding globulin in man. Clinical Pharmacology and Therapeutics 23: 47–53 (1978).
Angeli, A.; Agrimonti, F.; Frairia, R.; Vioino, P.L.; Barbadoro, E. and Ceresa, F.: Circadian patterns of plasma cortisol and testosterone in chronomic male alcoholics. International Journal of Chronobiology 7: 199 (1981).
Aschoff, J.: Comparative physiology; diurnal rhythms. Annual Review of Physiology 25: 581–600 (1963).
Avlisi, V.; Degli, U.E.; Longini, C.; Ruina, M.; Pavani, F.; Tralli, M. and Bagni, B.: Evidence of circadian rhythm of digoxin bioavailability. International Symposium of Clinical Chronopharmacy, Chronopharmacology and Chronotherapeutics (Tallahassee, Florida 1978).
Axelrod, J.: Control of catecholamine metabolism; in Gual and Ebling (Eds) Progress in Endocrinology. Proceedings of the 3rd International Congress Endocrinology, Mexico, pp.286–293 (Excerpta Medica International Congress Series No. 184, Amsterdam 1968).
Aymard, N. and Soulairac, A.: Chronobiological changes in pharmacokinetics of dipotassic clorazepate, a benzodiazepine; in Reinberg and Halberg Chronopharmacology, pp. 111–116 (Pergamon Press, Oxford 1979).
Bélanger, P.M.; Labrecque, G. and Dore, F.: Rate limiting steps in the temporal variations in the metabolism of selected drugs. International Journal of Chronobiology 7: 208 (1981).
Berg, W.C.; Jonkman, J.H.G.; Devries, K. and Orie, N.G.M.: Multi-dose comparative study of microcrystalline theophylline and choline theophyllinate. Current Medical Research and Opinion 6 (Suppl. 6): 64–70 (1979).
Bünning, E.: Die Physiologische Uhr. (Springer Verlag, Berlin 1963).
Carosella, L.; Di Nardo, P.; Bernabei, R.; Cocchi, A. and Carbonin, P.: Chronopharmacokinetics of digitalis. Circadian variations of beta-methyl-digoxin serum levels after oral administration; in Reinberg and Halberg (Eds) Chronopharmacology, pp. 125–134 (Pergamon Press, Oxford 1979).
Ceresa, F.: Chronopharmacological attempt to avoid the inhibitory corticoid effect during long-term treatment. Chronobiologia 1 (Suppl. 1): 271–278 (1974).
Ceresa, F.; Angeli, A.; Boccuzzi, G. and Molino, G.: Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. Journal of Clinical Endocrinology and Metabolism 29: 1704–1782 (1969).
Clench, J.; Reinberg, A.; Dziewanowska, J.; Ghata, J. and Dupont, J.: Chronopharmacokinetics of indomethacin in 9 healthy young human adults. Chronobiologia 4: 105 (1977).
Clench, J.; Reinberg, A.; Dziewanowska, Z.; Ghata, J. and Smolensky, M.: Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. European Journal of Clinical Pharmacology 20: 359–369 (1981).
Dettli, L. and Spring, P.: Diurnal variations in the elimination rate of a Sulfonamide in man. Helvetia Medica Acta 33: 291–306 (1966).
Di Santo, A.; Chodos, D. and Halberg, F.: Chronobioavailability of three erythromycin test preparations assessed by each of four indices: time to peak, peak, nadir and area. Chronobiologia 2 (Suppl. 1): 17 (1975).
Garrettson, L.K. and Jusko, W.J.: Diphenylhydantoin elimination kinetics in overdosed children. Clinical Pharmacology and Therapeutics 17: 481–491 (1975).
Goetz, F.; Bishop, J.; Halberg, F.; Sothern, R.; Brunning, R.; Senske, B.; Greeberg, B.; Minors, D.; Stoney, P.; Smith, I.; Rosen, G.; Cressey, D.; Haus, E. and Apfelbaum, M.: Timing of single daily meal influences relations among human circadian rhythms in urinary cyclic AMP hemic glucagon, insulin and iron. Experiemia 32: 1081–1084 (1976).
Grant, S.D.; Forsham, P.H. and Di Raimondo, V.C.: Suppression of 17-hydroxycorticosteroids in plasma and urine after single and divided doses of triamcinolone. New England Journal of Medicine 273: 1115–1118 (1965).
Halberg, F.: Chronobiology. Annual Review of Physiology 31: 675–725 (1969).
Halberg, F.; Gupta, E.D.; Haus, E.; Halberg, E.; Deka, A.C.; Nelson, W.; Sothern, R.B.; Cornelissen, G.; Klee, J.; Lakatua, D.J.; Scheving, L.E. and Burns, E.R.: Steps toward a cancer chronotherapy. 14th International Congress of Therapeutics, Montpellier, pp.151–196 (Expansion Scientifique, Paris 1977).
Haus, E.; Halberg, F.; Kuhl, J.F.W. and Lakatua D.J.: Chronopharmacology in animals; in Aschoff et al. (Eds) Chronobiological Aspects of Endocrinology. Chronobiologia 1 (Suppl. 1): 122–156 (1974).
Hrushesky, W.; Levi, F. and Kennedy, B.J.: Cis-diamminedichloroplatinum (DDP) toxicity to the human kidney reduced by circadian timing. Proceedings of the American Society for Clinical Oncology: 21 C45 (1980).
Hughes, A.; Jacabon, H.J.; Wagner, R.K. and Jungblut, P.W.: Ovarian independent fluctuations of estradiol receptor levels in mammalian tissues. Molecular and Cellular Endocrinology 5: 379–388 (1976).
Job, C.; Reinberg, A. and Delbarre, F.: Chronoeffectiveness of indomethacin in four patients suffering from evolutive coxarthrosis or ganarthrosis. International Journal of Chronobiology 7: 258 (1981).
Kyle, G.M.: Smolensky, M.H.; Thorne, L.G.; Hsi, B.; Robinson, A. and McGovern, J.P.: Circadian rhythm in the pharmacokinetics of orally administered theophylline; in Smolensky et al. (Eds) Recent Advances in the Chronobiology of Allergy and Immunology, pp.95–111 (Pergamon Press, Oxford, 1980a).
Kyle, G.M.; Smolensky, M.H.; Thome, L.G. and McGovern, J.P.: Indirect monitoring of theophylline blood levels utilizing saliva: a practical non-invasive approach to verifying dosage and understanding temporal variability in pharmacokinetics; in Smolensky et al. (Eds) Recent Advances in the Chronobiology of Allergy and Immunology, pp.123–128 (Pergamon Press, Oxford 1980b).
Labrecque, G.; Dore, F.; Laperriere, A.; Perusse, F. and Belanger, P.M.: Chronopharmacology. II. Variations in the carrageenininduced edema, in the action and the plasma levels of indomethacin; in Reinberg and Halberg (Eds) Chronopharmacology, pp.231–238 (Pergamon Press, Oxford 1979).
Lambinet, I.; Aymard, N.; Soulairac, A. and Reinberg, A.: Chronoptimization of lithium administration in five manic depressive patients: reduction of nephrotoxicity. International Journal of Chronobiology 7: 274 (1981).
Lesko, L.J.; Brousseau, D.; Canada, A.T. and Eastwood, G.: Temporal variations in trough serum theophylline concentrations at steady state. Journal of Pharmaceutical Sciences 69: 358–359 (1980).
Lévi, F.: Chronopharmacologie de trois agents doués d’activité anticancéreuse chez le rat et la souris: Chronoefficacité et chronotolérance. Thése de Doctorat és-Sciences (Paris VI), 1982.
Lévi, F.; Lakatua, D.; Haus, E.; Hrushesky, W.; Halberg, F.; Schwartz, S. and Kennedy, B.J.: Circadian urinary N-acetyl glucose amidinase (NAG) excretion gauges murine cisdiamminedichloroplatinum (DDP) nephrotoxicity. American Assocation of Cancer Research 21: 1232 (1980).
Markiewicz, A. and Semenowicz, K.: Time dependent changes in the pharmacokinetics of aspirin. International Journal of Clinical Pharmacology and Biopharmacy 17: 409–411 (1979a).
Markiewicz, A. and Semenowicz, K.: Chronokinetics of intestinal absorption and urinary excretion of xylose. Chronobiologia 6: 129 (1979b).
Markiewicz, A.; Semenowicz, K.; Korczynska, J. and Boldys, H.: Temporal variations in the response of ventilatory and circulatory functions to Propranolol in healthy man; in Smolensky et al. (Eds) Recent Advances in the Chronobiology of Allergy and Immunology, pp.185–193 (Pergamon Press, Oxford 1980).
Mattok, G.L. and McGilveray, J.; The effect of food intake and sleep on the absorption of acetaminophen. Revue Canadienne de Biologie 32 (Suppl. autome): 77–84 (1973).
McAllister, W.A.C.; Mitchell, D.M. and Collins, J.V.: Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. British Journal of Clinical Pharmacology 11: 303–304 (1981).
Minors, D.S. and Waterhouse, J.M.: Aspects of chronopharmacokinetics and chronergy of ethanol in healthy man. Chronobiologia 7: 465–480 (1979).
Montalbetti, N.: Non-interference in circadian rhythm during clinical use of corticoids; in Aschoff et al. (Eds) Chronobiological Aspects of Endocrinology. Chronobiologia 1 (Suppl. 1): 221–288 (1974).
Moore-Ede, M.C.: Circadian rhythms of drug effectiveness and toxicity. Clinical Pharmacology and Therapeutics 14: 925–935 (1973).
Moore-Ede, M.C.; Meguid, M.M.; Fitzpatrick, G.F.; Boyden, C.M. and Ball, M.R.: Circadian variation in response to potassium infusion. Clinical Pharmacology and Therapeutics 23: 218–227 (1978).
Morselli, P.L.; Marc, V.; Garattini, S. and Zaccala, M.: Metabolism of exogenous cortisol in humans — diurnal variations in plasma disappearance rate. Biochemical Pharmacology 19: 1643–1647 (1970).
Nair, V.: Circadian rhythms in drug action: a pharmacologic, biochemical and electron-microscopic study; in Scheving et al. (Eds) Chronobiology, pp.182–186 (Igaku Shoin, Tokyo 1974).
Nakano, S. and Hollister, L.E.: No circadian effect on nortriptyline kinetics in man. Clinical Pharmacology and Therapeutics 23: 199–203 (1978).
Pauly, J.E.; Burns, E.R.; Halberg, F.; Tsai, S.; Betterton, H.O. and Scheving, L.E.: Meal-timing dominates lighting regimen as a synchronizer of the eosinophil rhythm in mice. Acta Anatomy 93: 60–68 (1975).
Phillipens, K.M.H.; von Mayersbach, H. and Scheving, L.E.: Effects of the scheduling of meal-feeding at different phases of the circadian system in rats. Journal of Nutrition 107: 176–193 (1977).
Pöllmann, L.: Etude de 1a chronobiologie des dents. Revue Stomatologie. Chirurgie Maxillofaciale 82: 201–203 (1981).
Radzialowski, F.M. and Bousquet, W.F.: Daily rhythmic variation in hepatic drug metabolism in the rat and mouse. Journal of Pharmacology and Experimental Therapeutics 163: 229–238 (1968).
Reinberg, A.: Chronosusceptibility chronopharmacology (with special reference to corticosteroids). Folia Allergologica Immunologica Clinica 22: 559–569 (1975).
Reinberg, A.: Advances in human chronopharmacology. Chronobiologia 3: 151–166 (1976).
Reinberg, A.: Des rythmes biologiques à la chronobiologie, 3rd ed. (Gauthier-Villars, Paris 1979).
Reinberg, A.: Clinical chronopharmacology, an experimental basis for chronotherapy. Arzneimittel-Forschung 28: 1861–1867 (1978).
Reinberg, A.: Biological rhythms, sleep and drugs; in Wheatley (Ed.) Psychopharmacology of Sleep, pp.73–93 (Raven Press, New York 1981).
Reinberg, A.; Clench, J.; Aymard, N.; Gaillot, M.; Bourdon, R.; Gervais, P.; Abulker, C. and Dupont, J.: Variations circadiénnes des effets de l’éthanol et de l’éthanolémie chez l’homme adulte sain (étude chronopharmacologique). Journal de Physiologie (Paris) 70: 435–456 (1975a).
Reinberg, A.; Clench, J., Ghata, J.; Halberg, F.; Abulker, C., Dupont, J. and Zagula-Mally, Z.: Rythmes circadiens des paramétres de l’excrétion urinaire du salicylate (chronopharmacocinétique) chez l’homme adulte sain. Comptes-Rendus Académie des Sciences (Paris) 280: 1697–1700 (1975b).
Reinberg, A., Gervais, P., Morin, M. and Abulker, C.: Rythme circadien humain du seuil de la réponse bronchique á l’acétylcholine. Comptes-Rendus Académie des Sciences (Paris) 272: 1879–1881 (1971).
Reinberg, A.; Halberg, F. and Falliers, C.: Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1: 333–347 (1974).
Reinberg, A. and Ghata, J.: Les rythmes biologiques. Presses Universitaires de France Paris, 4th Ed. (1982).
Reinberg, A.; Guillet, P.; Gervais, P.; Ghata, J.; Vignaud, D. and Abulker, C.: One month chronocorticotherapy (Dutimelan 8-15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. Chronobiologia 4: 295–312 (1977).
Reinberg, A. and Halberg, F.: Circadian chronopharmacology. Annual Review of Pharmacology 11: 455–492 (1971).
Reinberg, A. and Halberg, F. (Eds): Chronopharmacology (Pergamon Press, Oxford 1978).
Reinberg, A. and Reinberg, M.: Circadian changes of the duration of action of local anaesthetic agents. Naunyn Schmiedeberg’s Archive Pharmacologie 297: 149–159 (1977).
Reinberg, A. and Smolensky, M.: Chronobiology (Springer-Verlag, New York; In press 1982).
Reinberg, A.; Zagula-Mally, Z.; Ghata, J. and Halberg, F.: Circadian rhythms in duration of salicylate excretion referred to phase of excretory rhythms and routine. Proceedings of the Society for Experimental Biology 124: 826–832 (1967).
Scheving, L.E.: Chronobiology: a new perspective in pharmacology and chemotherapy. Trends in Pharmacological Sciences 1: 303–307 (1980).
Scheving, L.W.; Burns, E.R.; Pauly, J.E.; Tsai, T.H.; Betterton, H.O. and Halberg, F.: Meal scheduling, cellular rhythms and the chronotherapy of cancer; in Koishi (Ed) Nutrition, pp.141–142 (Victory-sha Press, Kyoto 1976).
Scheving, L.E.; von Mayersbach, H. and Pauly, J.E.: An overview of chronopharmacology. European Journal of Toxicology 7: 203–227 (1974).
Scott, P.H.; Tabachnik, E.; Macleod, S.; Correia, J.; Newth, C. and Levison, H.: Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. Journal of Pediatrics 99: 476–479 (1981).
Segre, E.J. and Klaiber, E.L.: Therapeutic utilization of the diurnal variation of pituitary-adrenocorticol activity. California Medicine 104: 363–365 (1966).
Sharma, S.D.; Deshpande, V.A.; Samuel, M.R. and Vakil, B.J.: Chronobioavailability of ampicillin. Chronobiologia 6: 156 (1979).
Shively, C.A.; Simons, R.J.; Passananti, G.T.; Dvorchik, B.H. and Vesell, ES.: Dietary patterns and diurnal variations in aminopyrine disposition. Clinical Pharmacology and Therapeutics 29: 65–73 (1981).
Shively, C.A. and Vesell, E.S.: Temporal variations in acetaminophen and phenacetin half-life in man. Clinical Pharmacology and Therapeutics 18: 413–424 (1975).
Smolensky, M.: Rationale for circadian-system phased glucocorticoid management; in Scheving et al. (Eds) Chronobiology, pp. 197–201 (Igaku Shoin, Tokyo 1974).
Smolensky, M.H.; Kyle, M.G. and McGovern, J.P.: Circadian variation in the susceptibility of rodents to the toxic effects of theophylline; in Reinberg and Halberg (Eds) Chronopharmacology, pp.239–244 (Pergamon Press, Oxford 1979).
Smolensky, M.H.; Harrist, R.; Scott, P.H. Macleod, S.; Newth, C.; Levison, H. and Reinberg, A.: A chronobiologic evaluation of a sustained-release theophylline compound; in Takahashi and Halberg (Eds) Toward Chronopharmacology (Pergamon Press, Oxford, 1982. In press).
Smolensky, M.H.; Reinberg, A. and McGovern, J.P. (Eds): Recent Advances in the Chronobiology of Allergy and Immunology (Pergamon Press, Oxford 1980).
Smolensky, M.H.; Reinberg, A. and Queng, J.T.: The chronobiology and chronopharmacology of allergy. Annals of Allergy 47: 234–252 (1981).
Sturtevant, F.M.: Chronopharmacokinetics of ethanol. I. Review of the literature and theoretical considerations. Chronobiologia 3: 237–262 (1976).
Sturtevant, F.M.; Sturtevant, R.P.; Scheving, L.E. and Pauly, J.E.: Chronopharmacokinetics of ethanol. II. Orcadian rhythm in rate of blood level decline in a single subject. Archives of Pharmacology 293: 203–208 (1976).
Sturtevant, R.P. and Garber, S.L.: Changes in ethanol clearance rhythm in rats as affected by light-dark phase shifts and restricted feeding. Chronobiologia 6: 160 (1979).
Sturtevant, R.P. and Garber, S.L.: Orcadian variation in alcohol dehydrogenase activity levels in rats. International Journal of Chronobiology 7: 324 (1981).
Tarquini, B.; Romano, S.; de Scalzi, M.; de Leonardis, V.; Benvenuti, F.; Chegai, E.; Comparini, T.; Moretti, R. and Cagnoni, M.: Orcadian variations of iron absorption in healthy human subjects; in Reinberg and Halberg (Eds) Chronopharmacology, pp.347–354 (Pergamon Press, Oxford & New York 1979).
Touitou, Y.; Bogdan, A. and Reinberg, A.: Circadian changes in urinary steroid before, during and after a 36-hr 4-hourly sustained administration of metyrapone in eight healthy young human males. Journal of Steroid Biochemistry 7: 517–520 (1976).
Touitou, Y.; Touitou, C.; Bogdan, A.; Beck, H. and Reinberg, A.: Circadian rhythms in serum total proteins: observed differences according to age and mental health. Chronobiologia 6: 164 (1979).
von Mayersbach, H.: Die Zeitstruktur des Oragnismus. Arzneimittel-Forschung 28: 1824–1835 (1978).
Wirz-Justice, A.; Kafka, M.S.; Naber, D. and Wehr, T.A.: Circadian rhythms in rat brain: α- and β-adrenergic receptors are modified by chronic Imipramine. Life Sciences 27: 341–347 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reinberg, A., Smolensky, M.H. Circadian Changes of Drug Disposition in Man. Clin Pharmacokinet 7, 401–420 (1982). https://doi.org/10.2165/00003088-198207050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198207050-00002